Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model

Cited by (878)

Items 501–600 of 878

1. Epidemic Spreading in a Social Network With Facial Masks Wearing Individuals
   Duan‐Shin Lee, Miao Zhu · 2021 · IEEE Transactions on Computational Social Systems
2. Cerebellar infarction requiring surgical decompression in patient with COVID 19 pathological analysis and brief review
   Hiren N. Patel, Asma Syed, Jeffrey S. Lobel, Robert M. Galler, Joseph Georges, Margaret A. Carmody, Micheal Puumala · 2020 · Interdisciplinary Neurosurgery
3. Broad-spectrum antiviral activity of naproxen: from Influenza A to SARS-CoV-2 Coronavirus
   Olivier Terrier, Sébastien Dilly, Andrés Pizzorno, Julien Henri, Françis Berenbaum, Bruno Lina, Bruno Fève, Frédéric Adnet, Michèle Sabbah, Manuel Rosa‐Calatrava et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
4. Emergence of SARS and COVID-19 and preparedness for the next emerging disease X
   Ben Hu, Hua Guo, Haorui Si, Zhengli Shi · 2024 · Frontiers in Medicine
5. Challenges and opportunities in long COVID research
   Rebecca E. Hamlin, Catherine A. Blish · 2024 · Immunity
6. The reverse zoonotic potential of SARS-CoV-2
   Krista M. Milich, Stephen S. Morse · 2024 · Heliyon
7. SARS‐CoV‐2 surveillance for a non‐human primate breeding research facility
   J. Yee, K. V. van Rompay, A. Carpenter, P. Nham, B. Halley, Smita S. Iyer, D. Hartigan-O'Connor, C. Miller, Jeffrey A. Roberts · 2020 · Journal of medical primatology
8. In vitro characterisation of SARS‐CoV‐2 and susceptibility of domestic ferrets ( Mustela putorius furo )
   Glenn A. Marsh, Alexander J. McAuley, Sheree Brown, Elizabeth A. Pharo, Sandra G. Crameri, Gough G. Au, Michelle L. Baker, Jennifer A. Barr, Jemma Bergfeld, Matthew P. Bruce et al. · 2021 · Transboundary and Emerging Diseases
9. Variation in predicted COVID‐19 risk among lemurs and lorises
   Amanda Dawn Melin, Joseph Daniel Orkin, Mareike C. Janiak, Alejandro Valenzuela, Lukas F. K. Kuderna, Frank Marrone, Hasinala Ramangason, Julie E. Horvath, Christian Roos, Andrew C. Kitchener et al. · 2021 · American Journal of Primatology
10. A series of COVID ‐19 autopsies with clinical and pathologic comparisons to both seasonal and pandemic influenza
    Phillip McMullen, Peter Pytel, Alexis Snyder, Heather L. Smith, Jasmine Vickery, James Brainer, Robert D. Guzy, David Wu, Nathan Schoettler, Ayodeji Adegunsoye et al. · 2021 · The Journal of Pathology Clinical Research
11. Human neutralizing antibodies for SARS-CoV-2 prevention and immunotherapy
    Dongyan Zhou, Run-Hong Zhou, Zhi-Wei Chen · 2021 · Immunotherapy Advances
12. Systematic Tracing of Susceptible Animals to SARS-CoV-2 by a Bioinformatics Framework
    Hailiang Sun, Ailan Wang, Lixia Wang, Bing Wang, Geng Tian, Jialiang Yang, Ming Liao · 2022 · Frontiers in Microbiology
13. Transmissibility and pathogenicity of SARS-CoV-2 variants in animal models
    Young-Il Kim, Mark Anthony B. Casel, Young-Ki Choi · 2022 · Journal of Microbiology
14. Ferrets: A powerful model of SARS-CoV-2
    Yan Mei Zhao, 河北医科大学病原生物学教研室，河北 石家庄 050017，中国, Chang-Le Wang, Zhiyun Gao, Hongxiu Qiao, Weijie Wang, Xinyan Liu, Xia Chuai, 河北医科大学医学与健康研究所，河北 石家庄 050017，中国, 河北省胸科医院肿瘤科，河北 石家庄 050010，中国 · 2023 · 动物学研究
15. Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation
    K. V. van Rompay, K. Olstad, R. Sammak, Joseph C. Dutra, Jennifer K. Watanabe, J. Usachenko, Ramya Immareddy, Jamin W. Roh, A. Verma, Yashavanth Shaan Lakshmanappa et al. · 2022 · PLoS Pathogens
16. Anti-COVID-19 drug screening: Frontier concepts and core technologies
    Hua Luo, Mingming Zhao, Dechao Tan, Chang Liu, Lin Yang, Ling Qiu, Yan Gao, Hua Yu · 2020 · Chinese Medicine
17. COVID-19 Pandemic and Vaccines
    H. Qaiser, R. Abdullah, T. Iftikhar, Hammad Majeed, I. Imran · 2021 · Alternative Medicine Interventions for COVID-19
18. Surveillance strategies for SARS-CoV-2 infections through one health approach
    Chien-Yuan Huang, Shih‐Bin Su, Kow‐Tong Chen · 2024 · Heliyon
19. Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis
    Yeon-Woo Kang, Subin Park, Kun-Joo Lee, D. Moon, Young-Min Kim, Seung-Woo Lee · 2021 · Immune Network
20. Establishment of a humanized swine model for COVID-19
    Xuguang Du, Zihang Guo, Wenhui Fan, Tang Hai, Fei Gao, Pan Li, Yumin Qin, Chaolei Chen, Zhiqiang Han, Jilong Ren et al. · 2021 · Cell Discovery
21. Nonhuman primate models for evaluation of SARS-CoV-2 vaccines
    Jessica Anne Neil, Maryanne Griffith, Dale Ian Godfrey, Damian F. J. Purcell, Georgia Deliyannis, David Charles Jackson, Steve Rockman, Kanta Subbarao, Terry M. Nolan · 2022 · Expert Review of Vaccines
22. Ganoderma microsporum immunomodulatory protein acts as a multifunctional broad-spectrum antiviral against SARS-CoV-2 by interfering virus binding to the host cells and spike-mediated cell fusion
    Ha Phan Thanh Ho, Di Ngoc Kha Vo, Tung‐Yi Lin, Jo-Ning Hung, Ya-Hui Chiu, Ming‐Han Tsai · 2022 · Biomedicine & Pharmacotherapy
23. Generation and Characterization of a SARS-CoV-2-Susceptible Mouse Model Using Adeno-Associated Virus (AAV6.2FF)-Mediated Respiratory Delivery of the Human ACE2 Gene
    N. Tailor, B. Warner, B. Griffin, Kevin Tierney, E. Moffat, Kathy L. Frost, Robert Vendramelli, A. Leung, Marnie Willman, Sylvia P. Thomas et al. · 2022 · Viruses
24. Infectious diseases of neotropical primates
    Ayisa Rodrigues Oliveira, Renato L. Santos · 2023 · Brazilian Journal of Veterinary Pathology
25. Risk assessment of SARS-CoV-2 replicating and evolving in animals
    Jin Zhao, Mei Kang, Hongyan Wu, Bowen Sun, Guy Baele, Wanting He, Meng Lu, Marc A. Suchard, Xiang Ji, Na He et al. · 2023 · Trends in Microbiology
26. Newly Emerging Human Coronaviruses: Animal Models and Vaccine Research for SARS, MERS, and COVID-19
    Pureum Lee, Doo-Jin Kim · 2020 · Immune Network
27. COVID-19–Associated Acute Respiratory Distress Syndrome
    Elizabeth A. Middleton, G. Zimmerman · 2021 · Critical care clinics
28. Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19
    Yang Liu, Yankang Wu, Bing Liu, Youpeng Zhang, Dan San, Yu Chen, Yu Zhou, Long Yu, Haihong Zeng, Yun Zhou et al. · 2021 · Frontiers in Immunology
29. Germinal Center-Induced Immunity Is Correlated With Protection Against SARS-CoV-2 Reinfection But Not Lung Damage
    Green Kim, D. H. Kim, H. Oh, Seongman Bae, Ji-Soo Kwon, Min-Jae Kim, Eunyoung Lee, Eun-Ha Hwang, Hoyin Jung, Bon-Sang Koo et al. · 2021 · Journal of Infectious Diseases
30. Comparative Pathogenesis of Severe Acute Respiratory Syndrome Coronaviruses
    Jingshu Zhang, Melanie Rissmann, Thijs Kuiken, Bart L. Haagmans · 2023 · Annual Review of Pathology Mechanisms of Disease
31. Development of a Novel Multiplex PCR Method for the Rapid Detection of SARS-CoV-2, Influenza A Virus, and Influenza B Virus
    Liang Ma, Haoyan Zhu, Yongwei Jiang, Xiaomu Kong, Peng Gao, Yi Liu, Meimei Zhao, Guoxiong Deng, Yongtong Cao · 2024 · International Journal of Analytical Chemistry
32. Preclinical animal models to evaluate therapeutic antiviral antibodies.
    Amse De Meyer, P. Meuleman · 2024 · Antiviral Research
33. Differential beta‐coronavirus infection dynamics in human bronchial epithelial organoids
    Dongbin Park, Se‐Mi Kim, Ho Bin Jang, Kanghee Kim, Ho Young Ji, Heedong Yang, Woohyun Kwon, Yeong-Lim Kang, Suhee Hwang, Hyunjoon Kim et al. · 2024 · Journal of Medical Virology
34. RETRACTED: Fragments SARS-Cov-2 in aquatic organism represent an additional environmental risk concern: Urgent need for research
    Ives Charlie‐Silva, Guilherme Malafaia · 2022 · The Science of The Total Environment · Retracted
35. Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters
    Melanie Rissmann, Danny Noack, Debby A.J. van Riel, Katharina S. Schmitz, Rory D. de Vries, Peter van Run, Mart Matthias Lamers, Corine H. GeurtsvanKessel, Marion Koopmans, Ron A. M. Fouchier et al. · 2022 · Emerging Microbes & Infections
36. The dynamics of γδ T cell responses in nonhuman primates during SARS-CoV-2 infection
    Alyssa C. Fears, Edith M. Walker, Nicole R. Chirichella, Nadia Slisarenko, Kristen M. Merino, Nadia Golden, Breanna Picou, Skye Spencer, Kasi Russell‐Lodrigue, Lara A. Doyle‐Meyers et al. · 2022 · Communications Biology
37. Susceptibility of domestic and companion animals to SARS-CoV-2: a comprehensive review
    Ali Mohammad Pourbagher‐Shahri, Gholamreza Mohammadi, Hamed Ghazavi, Fatemeh Forouzanfar · 2023 · Tropical Animal Health and Production
38. Induced Pluripotent Stem Cell-Derived Organoids: Their Implication in COVID-19 Modeling
    Mária Csöbönyeiová, Martin Klein, Marcela Kuniaková, Ivan Varga, Ľuboš Danišovič · 2023 · International Journal of Molecular Sciences
39. A tissue specific-infection mouse model of SARS-CoV-2
    Bo Yeun Yang, Chao Liu, Xiaohui Ju, Bingbing Wu, Zhuangfei Wang, Fucheng Dong, Yanying Yu, Xiaohui Hou, Min Fang, Fei Gao et al. · 2023 · Cell Discovery
40. Temperature impacts SARS-CoV-2 spike fusogenicity and evolution
    Jérémy Dufloo, Rafael Sanjuán · 2024 · mBio
41. New technologies in therapeutic antibody development: The next frontier for treating infectious diseases
    Sheila Marie Keating, Brett Higgins · 2024 · Antiviral Research
42. Animal Models to Study Emerging Technologies Against SARS-CoV-2
    Jhinuk Basu Mullick, C. Simmons, Janak Gaire · 2020 · Cellular and Molecular Bioengineering
43. Clinical-Pathological Correlation of the Pathophysiology and Mechanism of Action of COVID-19 — a Primer for Clinicians
    Jeremy Chee, Woei Shyang Loh, Zheng Liu, Joaquim Mullol, De Yun Wang · 2021 · Current Allergy and Asthma Reports
44. Using in vivo animal models for studying SARS-CoV-2
    Camila Braz Pereira da Costa, Ana Claudia de Menezes Cruz, Julio Cesar Queiroz Penha, Helena Carla Castro, Luís Eduardo Ribeiro da Cunha, Norman Arthur Ratcliffe, Rafael Cisne, Francislene Juliana Martins · 2021 · Expert Opinion on Drug Discovery
45. Computed tomography and [18F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates
    Thibaut Naninck, Nidhal Kahlaoui, Julien Lemaître, Pauline Maisonnasse, Antoine de Mori, Quentin Pascal, Vanessa Contreras, Romain Marlin, Francis Relouzat, Benoît Delache et al. · 2022 · iScience
46. A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19
    Zemene Demelash Kifle, Alem Endeshaw Woldeyohanins, Chilot Abiyu Demeke · 2021 · Metabolism Open
47. Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection
    Guidenn Sulbarán, Pauline Maisonnasse, Axelle Amen, Grégory Effantin, Delphine Guilligay, Nathalie Dereuddre‐Bosquet, Judith A. Burger, Meliawati Poniman, Marloes Grobben, Marlyse Buisson et al. · 2022 · Cell Reports Medicine
48. COVID-19 and the workplace: Research questions for the aerosol science community
    William G. Lindsley, Françoise M. Blachère, Nancy Clark Burton, Brian Christensen, Cheryl Fairfield Estill, Edward M. Fisher, Stephen B. Martin, Kenneth R. Mead, John D. Noti, Melissa Seaton · 2020 · Aerosol Science and Technology
49. Conserved role of spike S2 domain N-glycosylation across betacoronaviruses
    Qi Yang, Anju Kelkar, Balaji Manicassamy, Sriram Neelamegham · 2025 · npj Viruses
50. Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2
    Reut Falach, Liat Bar‐On, Shlomi Lazar, Tamar Kadar, Ohad Mazor, Moshe Aftalion, David Gur, Yentl Evgy, Ohad Shifman, Tamar Aminov et al. · 2021 · JCI Insight
51. Susceptibility of Domestic Goat (Capra aegagrus hircus) to Experimental Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.351/Beta Variant
    Leira Fernández‐Bastit, Núria Roca, Miguel Romero‐Durana, Jordi Rodon, Guillermo Cantero, Óscar García, Carlos López-Figueroa, Mónica Pérez, R. López-Jiménez, Jorge Carrillo et al. · 2022 · Viruses
52. Long-read assembly of major histocompatibility complex and killer cell immunoglobulin-like receptor genome regions in cynomolgus macaque
    Qingxiu Hu, Xiaoqi Huang, Yabin Jin, Rui Zhang, Aimin Zhao, Yiping Wang, Chenyun Zhou, Weixin Liu, Xunwei Liu, Chunhua Li et al. · 2022 · Biology Direct
53. Efficacy of Interferon Gamma in the Prevention of SARS-CoV-2 Infection (COVID-19): Results of a Prospective Controlled Trial
    Alexander Myasnikov, Svetlana A. Berns, К В Зверев, О. А. Ларцева, P. A. Talyzin · 2020 · International Journal of Biomedicine
54. Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo
    Ruby A. Escobedo, D. Singh, D. Kaushal · 2021 · Frontiers in Immunology
55. Animal models for studying COVID-19, prevention, and therapy: Pathology and disease phenotypes
    Shambhunath Choudhary, Isis Kanevsky, Lindsay Tomlinson · 2022 · Veterinary Pathology
56. Animal models for studying coronavirus infections and developing antiviral agents and vaccines
    Qisheng Lin, Chunni Lu, Yuqi Hong, Runfeng Li, Jinding Chen, Weisan Chen, Jianxin Chen · 2022 · Antiviral Research
57. Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates
    Antoni Prenafeta, Gregori Bech-Sàbat, Alexandra Moros, Antonio Barreiro, Alex Fernández, Manuel Cañete, Mercè Roca, Luis González‐González, Carme Garriga, Joachim Confais et al. · 2023 · iScience
58. Does Peer Reviewing for COVID-19-Related Papers Still Work?
    Octavio Orellana‐Serradell, Magda C. Díaz‐Vesga, María Fernanda González, Myriam Gutiérrez, Daniela Herrera, Daniela Jara, Diego Maureira, Jenny Laura Ruiz-Fuentes, Sofía Sanhueza, Lisette Leyton · 2020 · Frontiers in Research Metrics and Analytics
59. Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review
    Mudit Agarwal, Piyush Ranjan, Upendra Baitha, Ankit Mittal · 2020 · Frontiers in Pharmacology
60. COVID Obesity: A One-Year Narrative Review
    Diana L. Palacios Ovalle, Susana Rodrigo-Cano, Aránzazu González, Carla Soler, A.I. Catalá-Gregori, Juan Francisco Merino-Torres, José Miguel Soriano · 2021 · Nutrients
61. The 249RWMD spike protein insertion in Omicron BQ.1 subvariant compensates the 24LPP and 69HV deletions and may cause severe disease than BF.7 and XBB.1 subvariants
    Asit Kumar Chakraborty · 2023 · Research Square
62. Variable DPP4 expression in multiciliated cells of the human nasal epithelium as a determinant for MERS-CoV tropism
    Tim I. Breugem, Samra Riesebosch, Jing Shu Zhang, Anna Z. Mykytyn, Lisette Krabbendam, Nathalie Gröen, Stephanie Varela, Debby Schipper, Petra B. van den Doel, Romy van Acker et al. · 2025 · Proceedings of the National Academy of Sciences
63. Severe acute respiratory syndrome coronavirus 2 for physicians: Molecular characteristics and host immunity (Review)
    Jin Shang, Lingyao Du, Ning Han, Duoduo Lv, Jiayi Wang, Hailing Yang, Lang Bai, Hong Tang · 2021 · Molecular Medicine Reports
64. Exploring NFkB pathway as a potent strategy to mitigate COVID-19 severe morbidity and mortality
    Mubarak Muhammad, Tasneem M. Hassan, Sani S. Baba, Mustapha Ismail Radda, MubarakM Mutawakkil, MajidaA Musa, Sazaly AbuBakar, Shih Keng Loong, Ibrahim Yusuf · 2022 · Journal of Public Health in Africa
65. Algae Polysaccharides (Carrageenan and Alginate)—A Treasure-Trove of Antiviral Compounds: An In Silico Approach to Identify Potential Candidates for Inhibition of S1-RBD Spike Protein of SARS-CoV2
    Dikshansha Rohilla, Akhileshwar Kumar Srivastava, Rahul Prasad Singh, Priya Yadav, Sandeep Kumar Singh, Dharmendra Kumar, Nikunj Bhardwaj, Mahipal Singh Kesawat, Kapil Deo Pandey, Ajay Kumar · 2023 · Stresses
66. Perspectives on SARS-CoV-2 Cases in Zoological Institutions
    Remco A. Nederlof, M. A. de la Garza, J. Bakker · 2024 · Veterinary Sciences
67. Selective phosphodiesterase 4 inhibitor roflumilast reduces inflammation and lung injury in models of betacoronavirus infection in mice
    Vinícius Amorim Beltrami, Flávia Rayssa Braga Martins, Débora Gonzaga Martins, Celso Martins Queiroz‐Junior, Franciel Batista Félix, Letícia Cassiano Resende, Felipe Rocha da Silva Santos, Larisse de Souza Barbosa Lacerda, Victor Rodrigues de Melo Costa, Walison Nunes da Silva et al. · 2025 · Inflammation Research
68. Distinct transcriptional responses to fatal Ebola virus infection in cynomolgus and rhesus macaques suggest species-specific immune responses
    Amanda N. Pinski, Kevin J. Maroney, Andrea Marzi, Ilhem Messaoudi · 2021 · Emerging Microbes & Infections
69. A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) Variant
    Albert To, Teri Ann S. Wong, Michael M. Lieberman, Karen Sue Thompson, Aquena H. Ball, Laurent Pessaint, Jack J. Greenhouse, Nisrine Daham, Anthony Cook, Brandon Narvaez et al. · 2022 · ACS Infectious Diseases
70. In vitro high-content tissue models to address precision medicine challenges
    Samson Afewerki, T. Stocco, Andre Diniz Rosa da Silva, André Sales Aguiar Furtado, Gustavo Fernandes de Sousa, G. Ruiz-Esparza, T. Webster, F. R. Marciano, M. Strømme, Y. Zhang et al. · 2022 · Molecular Aspects of Medicine
71. COVID-19 vs. Cancer Immunosurveillance: A Game of Thrones within an Inflamed Microenviroment
    Ioannis Liapis, Stavroula Baritaki · 2022 · Cancers
72. Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
    Efstathios S. Giotis, Emine Cil, Greg Nicholas Brooke · 2022 · Viruses
73. Current state-of-the-art and potential future therapeutic drugs against COVID-19
    Ailong Sha, Yi Liu, Haiyan Hao · 2023 · Frontiers in Cell and Developmental Biology
74. Tissue Proteases and Immune Responses: Influencing Factors of COVID-19 Severity and Mortality
    Natália Mulinari Turin de Oliveira, Isabella Fernandes da Silva Figueiredo, Liziane Cristine Malaquias da Silva, Karien Sauruk da Silva, Laryssa Regis Bueno, Bruna Barbosa da Luz, Cláudia Rita Corso, Maria Fernanda Paula Werner, Elizabeth Soares Fernandes, Daniele Maria Ferreira · 2020 · Pathogens
75. The potential use of Drosophila as an in vivo model organism for COVID-19-related research: a review
    E. Demir · 2021 · Turkish journal of biology = Turk biyoloji dergisi
76. Human Organoids as a Promising Platform for Fighting COVID-19
    Dong Chen, Xi Su, Haibo Chen, Siyan Chen, Yongsheng Zhao, Wei Wei · 2022 · International Journal of Biological Sciences
77. A Recombinant Protein SARS-CoV-2 Candidate Vaccine Elicits High-titer Neutralizing Antibodies in Macaques.
    G. Baisa, David Rancour, K. Mansfield, Monika Burns, Lori Martin, D. Cunha, J. Fischer, Frauke Muecksch, T. Hatziioannou, P. Bieniasz et al. · 2021 · Research Square
78. Respiratory infections due to human common cold coronaviruses, SARS-CoV, MERS-CoV, and SARS-CoV-2: epidemiology, pathogenesis, clinical features, diagnostics, therapeutics, and vaccine landscapes
    Alimuddin I. Zumla, David S.C. Hui, Malik J. S. Peiris, Stanley M. Perlman · 2026 · The Lancet Respiratory Medicine
79. Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements
    Giorgio Frega, Andrea Palloni, Giuseppe Di Pasquale, Gioconda Saccoccio, Alessandro Rizzo, Elisabetta Poluzzi, Primiano Iannone, Giovanni Brandi · 2020 · Frontiers in Pharmacology
80. Diseased lungs may hinder COVID-19 development: A possible reason for the low prevalence of COPD in COVID-19 patients
    Shin Jie Yong · 2021 · Medical Hypotheses
81. Activation of Immune System May Cause Pathophysiological Changes in the Myocardium of SARS-CoV-2 Infected Monkey Model
    Maryam Rabbani, Jay Rappaport, Manish Gupta · 2022 · Cells
82. Aptamer-Linked Photonic Crystal Assay for High-Throughput Screening of HIV and SARS-CoV-2
    Aysha Sarfraz Rizvi, Ghulam Murtaza, Xu Xu, Peifeng Gao, Lili Qiu, Zihui Meng · 2022 · Analytical Chemistry
83. Fake News, Misinformation, and Privacy: How the COVID-19 Pandemic Changes Our Society and How Blockchain and Distributed Ledger Technologies Reduce Their Effects
    Kevin K.W. Ho, Dickson K.W. Chiu, Cheuk Hang Au, Francis S. Dalisay, Stuart C.K. So, Masahiro Yamamoto · 2023 · Distributed Ledger Technologies Research and Practice
84. The Impact and Effects of Host Immunogenetics on Infectious Disease Studies Using Non-Human Primates in Biomedical Research
    Neil J. Berry, Edward T Mee, Neil M. Almond, Nicola J. Rose · 2024 · Microorganisms
85. State of the Art in 3D Culture Models Applied to Thyroid Cancer
    Alessandro Prete, Antonio Matrone, Roberto Plebani · 2024 · Medicina
86. Neurological manifestations of severe acute respiratory syndrome coronavirus 2—a controversy ‘gone viral’
    Moritz Förster, Vivien Weyers, Patrick Küry, Michael Harry Barnett, Hans‐Peter Hartung, David Kremer · 2020 · Brain Communications
87. Virus systems biology: Proteomics profiling of dynamic protein networks during infection
    Kevin Klann, Georg Tascher, Christian Münch · 2021 · Advances in virus research
88. Olfactory and taste dysfunctions in COVID-19
    Philip W. Rouadi, Samar A. Idriss, Jean Bousquet · 2021 · Current Opinion in Allergy and Clinical Immunology
89. Chronic rhinosinusitis is associated with increased risk of COVID-19 hospitalization
    Firas Sbeih, Jorge Gutierrez, George Saieed, Mohamad R. Chaaban · 2022 · American Journal of Otolaryngology
90. Sphingosine-1-Phosphate as Lung and Cardiac Vasculature Protecting Agent in SARS-CoV-2 Infection
    Manale Karam, Christian Auclair · 2023 · International Journal of Molecular Sciences
91. Fundamentals of genomic epidemiology, lessons learned from the coronavirus disease 2019 (COVID-19) pandemic, and new directions
    Denis Jacob Machado, Richard Allen White III, Janice Kofsky, Daniel A. Janies · 2021 · Antimicrobial Stewardship & Healthcare Epidemiology
92. Proteomic and Metabolomic Characterization of SARS-CoV-2-Infected Cynomolgus Macaque at Early Stage
    Tiecheng Wang, Faming Miao, Shengnan Lv, Liang Li, Wei Feng, Lihua Hou, Renren Sun, Wei Li, Jian Zhang, Cheng Zhang et al. · 2022 · Frontiers in Immunology
93. Investigating SARS-CoV-2 Susceptibility in Animal Species: A Scoping Review
    C. Rutherford, Pratap Kafle, C. Soos, T. Epp, L. Bradford, E. Jenkins · 2022 · Environmental Health Insights
94. Seasonal variations in Nigeria: understanding COVID-19 transmission dynamics and immune responses
    Oluwamuyiwa Ayanshina, Adeleye Oluwatosin Adeshakin, Lukman Olalekan Afolabi, Funmilayo Oladunni Adeshakin, Ganiyu O. Alli‐Balogun, Dehong Yan, Samuel Essien‐Baidoo, Xiaochun Wan · 2020 · Journal of Global Health Reports
95. LIF and the lung’s Stem Cell Niche: is Failure to Use LIF to Protect Against COVID-19 a Grave Omission in Managing the pandemic?
    Su M Metcalfe · 2020 · Future Virology
96. Expression of SARS-CoV-2 entry receptor ACE2 in human brain and its association with Alzheimer’s disease and COVID-19
    Sijie Li, Jingyi Sun, He Li, Zhifa Han, Tao Wang, Shan Gao, Ping Zhu, Yan Chen, Peiguang Yan, Mingxin Wang et al. · 2025 · Molecular Psychiatry
97. Assessment of SARS-CoV-2 immune escape using antigenic cartography combined with experimental challenge studies
    Merel R Te Marvelde, Anna Z. Mykytyn, Edwin J. B. Veldhuis Kroeze, Alexandre Bouffier, Debby van Eck—Schipper, Petra van den Doel, Kim Handrejk, Björn F. Koel, Melanie Rissmann, Bart L. Haagmans · 2026 · npj Vaccines
98. Plitidepsin as an Immunomodulator against Respiratory Viral Infections
    Alejandro Losada, Nuria Izquierdo‐Useros, Pablo M. Aviles, Júlia Vergara‐Alert, Irene Latino, Joaquím Segalés, Santiago González, Carmen Cuevas, Dàlia Raïch Regué, María José Muñoz-Alonso et al. · 2024 · The Journal of Immunology
99. Resistance to SARS-CoV-2 infection in camelid nasal organoids is associated with lack of ACE2 expression
    Tim I. Breugem, Samra Riesebosch, Debby Schipper, Anna Z. Mykytyn, Petra van den Doel, Joaquím Segalés, Mart Matthias Lamers, Bart L. Haagmans · 2024 · npj Viruses
100. Whole-body visualization of SARS-CoV-2 biodistribution in vivo by immunoPET imaging in non-human primates
     Alexandra Detrille, Steve Huvelle, Marit J. van Gils, Tatiana Geara, Quentin Pascal, Jonne L. Snitselaar, Laëtitia Bossevot, Mariangela Cavarelli, Nathalie Dereuddre‐Bosquet, Francis Relouzat et al. · 2025 · Nature Communications